• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.29% Nasdaq Up 6.19%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    5.04 Down 0.04(0.79%) Jul 22, 4:00PM EDT
    Prev Close:5.08
    Open:5.06
    Bid:5.01 x 500
    Ask:5.28 x 1000
    1y Target Est:6.30
    Beta:0.322913
    Next Earnings Date: 4-Aug-16TROV Earnings announcement
    Day's Range:5.02 - 5.27
    52wk Range:2.85 - 8.80
    Volume:363,312
    Avg Vol (3m):451,238
    Market Cap:150.50M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):495.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.30
    Quarterly EPS Est (Jun-16) :-0.31
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback